The dermatology market’s allure lies in its promising market dynamics, including opportunities for consolidating practices, leveraging economies of scale, and optimizing operational efficiencies. Additionally, the growing consumer awareness and emphasis on skin health have contributed to a robust and expanding market demand. With relatively favorable reimbursement structures, evolving regulations, and technological advancements supporting the sector, PE firms are keen to invest in dermatology practices and capitalize on their growth potential, VMG Health reports. Read more.
Related Posts
Best Buy, Samsung Placing Big Bets on Home Health Care
Most adults 50 and older (77%) want to remain in their homes for the long term, data show.
March 14, 2022
Health-Care Staffing Agencies See Tightened Rules Following Covid Era
The recent growth in such agencies has led many state legislatures to enact new licensure or registration requirements.
June 7, 2023
Silicon Valley Bank Projects Healthcare Financing to Fall by $15B in 2023
Still, "looking ahead to 2023, while there is still uncertainty in the private investment landscape, the strongest companies will get funded," SVB Managing Director Jonathan Norris said.
January 9, 2023
Justice Department Dropping Antitrust Case Against UnitedHealth’s SCA Health
In January 2021, a federal grand jury charged SCA and its related entities, which own and operate outpatient medical care centers, with entering and engaging in conspiracies with other healthcare companies to suppress competition between them for the services of senior-level employees. SCA is part of UnitedHealth Group's Optum division.
November 15, 2023